Govt confirms Patanjali can sell its drug but not as `cure’ to COVID-19
PTI, Jul 1, 2020, 4:59 PM IST
Haridwar/New Delhi: Yoga guru Ramdev’s Patanjali Ayurved on Wednesday, July 1 said there are no AYUSH Ministry restrictions on selling Coronil, a drug the company recently launched as medicine for COVID-19 but is now calling it a product to “manage” the disease.
The Union ministry confirmed that Patanjali can sell the product but not as a cure for COVID-19.
“AYUSH Ministry has only given permission to sell this particular formulation as an immunity booster and not as a medicinal cure for COVID-19,” it said.
At a press conference in Haridwar, Ramdev claimed the ministry has said that Patanjali did an “an appropriate job for COVID-19 management”.
“I want to tell people who want to try these medicines that there is no restriction on their sale now and they will be available in a kit everywhere in the country from today,” he added, referring to Coronil and the two other products Patanjali is promoting together.
Ramdev said the Union ministry had asked him to use the term “COVID management” in place of “COVID treatment” and he is following the instruction.
Even while backtracking on the describing Coronil as “treatment” for COVID-19, the company stuck to its claim that the drug’s trial on mild to moderately ill patients was successful.
Its press note said the trial, conducted after the necessary approvals, showed 100 percent recovery of patients within seven days.
It said the AYUSH Ministry has “categorically agreed” that Patanjali had “appropriately worked on COVID-19 management”.
“Now there is no difference of opinion between AYUSH Ministry and Patanjali,” it added.
“As per the ministry, Patanjali is allowed to manufacture and distribute its Diva Coronil tablet, Divya Swasari Vati, and Divya Anu Talia across India, as per the manufacturing licenses granted by State Licensing Authority, Ayurvedic and Unani Services, Govt of Uttarakhand,” it said.
The Uttarakhand department was among the agencies which had questioned Patanjali’s claim to have developed a drug to cure COVID-19. It said the company had only been given a license to manufacture an immunity booster.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
PM Modi leaves for home after concluding three-nation visit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kerala HC quashes FIR against Goa Guv over remarks on Sabarimala women entry
Smriti Irani embarks on four-nation tour to promote book on PM Modi
Karnataka Milk Federation enters Delhi-NCR, offers competitive pricing on Nandini products
MUST WATCH
Latest Additions
‘Bengaluru Chalo’ protest demand rejection of Kasturirangan Report
Mangaluru: Cyber frauds posing as TRAI representatives fleece Rs 1.71 crore
10 month baby gets new heart, new life
Saura Swasthya launched: Karnataka to power 5,000 health facilities with solar energy
India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.